Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
I. Kwiecien (Warszawa, Poland), E. Rutkowska (Warszawa, Poland), J. Bednarek (Warszawa, Poland), R. Sokolowski (Warszawa, Poland), K. Jahnz- Rózyk (Warszawa, Poland), J. Domagala-Kulawik (Warszawa, Poland), P. Rrzepecki (Warszawa, Poland). T cell maturation profile in metastatic vs. non-metastatic lymph nodes in NSCLC patients. 681

Member's Comments

No comment yet.

Related content which might interest you: PD-L1 expression on lung cancer stem cells in metastatic lymph nodes. Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management Year: 2018 Accuracy of re-mediastinoscopy and fusion PET-CT in the assessment of lymph node (LN) downstaging after induction chemotherapy for N2 non-small cell lung cancer (NSCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 602s Year: 2006 Immunomodulating properties of FasL+ lung cancer cells identified in lymph nodes aspirates of NSCLC patients Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 Different morphological changes in non-small cell lung cancers and their corresponding lymph node metastases after neoadjuvant therapy? Source: Eur Respir J 2004; 24: Suppl. 48, 479s Year: 2004 An usual metastasis of squamous cell lung cancer: intra-abdominal lymph nodes Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer Year: 2009 Correlation between p53 expression in bronchus biopsies from non-small cell lung cancer cases and mediastinal lymph node invasion demonstrated through mediastinoscopy Source: Eur Respir J 2006; 28: Suppl. 50, 82s Year: 2006 Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Central tumor location and presence of occult lymph node metastasis in cT1N0M0 NSCLC Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019 Lymph nodes frozen section in staging of non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 534s Year: 2005 Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement Source: Eur Respir J 2007; 30: 21-26 Year: 2007 Immunomodulating properties of PD-L1 positive cancer stem cells in metastatic lymph nodes Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer Year: 2019 Prevalence of silent brain metastasis (BM) in the initial staging of non-small cell lung carcinoma (NSCLC) Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011 Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment Source: Eur Respir J 2009; 33: 1383-1388 Year: 2009 Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT Source: Annual Congress 2007 - Diagnosis of thoracic malignancies Year: 2007 Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer Source: Eur Respir J 2013; 41: 649-655 Year: 2013 Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant. A prospective study Source: Eur Respir J 2007; 30: Suppl. 51, 206s Year: 2007 Mediastinal lymph node staging with spiral CT and FDG-PET in patients with non-small cell lung cancer (NSCLC). Avoidable thoracotomies Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging Year: 2004 Lung cancer size and thoracic lymph nodes metastatic involvement: a correlation Source: Eur Respir J 2004; 24: Suppl. 48, 671s Year: 2004 Lung cancer size and thoracic lymph nodes metastatic involvement: A correlation Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011